Your browser doesn't support javascript.
loading
An approach to the design of novel cognitive enhancers using molecular modeling and X-ray crystallography.
Nugiel, D A; Voss, M E; Brittelli, D R; Calabrese, J C.
Afiliación
  • Nugiel DA; Du Pont Merck Pharmaceutical Company, Wilmington, DE 19880-0353, USA.
Drug Des Discov ; 12(4): 289-95, 1995 Apr.
Article en En | MEDLINE | ID: mdl-9040989
A novel series of cognition enhancers was designed based on molecular modeling and X-ray structure analysis of EXP-9121 (2). This new series features a spirocyclic ring system that constrains the side chain substituents into the orientation seen in the X-ray crystal structure of 2. MM2 calculations preformed on 2 accurately predicted the solid state conformation. Compounds could be rapidly assembled using a bis-Michael addition reaction. Unfortunately, in vitro testing showed moderate activity at best, suggesting the X-ray structure of 2 does not mimic the bioactive conformation.
Asunto(s)
Buscar en Google
Banco de datos: MEDLINE Asunto principal: Piridinas / Nootrópicos Tipo de estudio: Prognostic_studies Límite: Animals Idioma: En Revista: Drug Des Discov Asunto de la revista: FARMACOLOGIA Año: 1995 Tipo del documento: Article País de afiliación: Estados Unidos
Buscar en Google
Banco de datos: MEDLINE Asunto principal: Piridinas / Nootrópicos Tipo de estudio: Prognostic_studies Límite: Animals Idioma: En Revista: Drug Des Discov Asunto de la revista: FARMACOLOGIA Año: 1995 Tipo del documento: Article País de afiliación: Estados Unidos